Lv5
1050 积分 2025-08-21 加入
Type 2 diabetes: summary of updated NICE guidance
23天前
已完结
Particulate matter of air pollution may increase risk of kidney failure in IgA nephropathy
28天前
已完结
Aldosterone and Treatment-Resistant Hypertension
29天前
已完结
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
30天前
已完结
Asian Expert Consensus on Nocturnal Hypertension Management
30天前
已完结
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes
30天前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
1个月前
已完结
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
1个月前
已完结
Semaglutide administration protects cardiomyocytes in db/db mice via energetic improvement and mitochondrial quality control
1个月前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
1个月前
已完结
皖公网安备34019202002308
